05/30/2024
3:38 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:51 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:45 PM | Neurocrine Biosciences (Issuer)
POON CHRISTINE A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:59 PM | Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:02 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:17 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:21 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/23/2024
5:26 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:29 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:34 PM | Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:27 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:35 PM | Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:15 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:57 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:06 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:51 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:46 PM | Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:31 PM | Neurocrine Biosciences (Subject)
Norwalk Leslie V (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
3:31 PM | Neurocrine Biosciences (Subject)
Sharp Shalini (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
3:32 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
3:40 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:23 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:26 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
6:03 AM | Neurocrine Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024
4:19 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024
3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024
3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024
3:44 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
5:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:20 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:25 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:33 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:15 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:19 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:32 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:33 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:47 PM | Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
03/08/2024
3:22 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:22 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:55 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:11 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:51 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:40 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:43 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:45 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:48 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:27 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:17 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
3:18 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2024
6:46 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:25 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:28 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:12 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:15 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:24 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:26 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:29 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:00 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:05 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:11 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:14 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:43 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:04 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:47 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
10:52 AM | BlackRock Inc. (Filed by)
Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024
3:17 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:31 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
[Urgent!] Generational Wealth Gameplan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
01/08/2024
3:15 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:26 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:32 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Neurocrine Biosciences (Subject)
RASTETTER WILLIAM H (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:31 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:08 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:10 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:15 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:21 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
